Palantir Technologies ( PLTR ) has achieved a significant milestone. The company was granted FedRAMP High Authorization for its Palantir Federal Cloud Service (PFCS) and Supporting Services (PFCS-SS). This certification enables Palantir to offer its full suite of products, including its Artificial Intelligence Platform (AIP), Apollo, Foundry, and Gotham, to U.S. government agencies at the highest level of security for unclassified workloads. The FedRAMP High authorization positions Palantir as a trusted partner for critical federal missions, expanding its reach across civilian, defense, and intelligence agencies. Akash Jain, President and CTO of Palantir USG, stated, "This milestone is an affirmation of our commitment to upholding the highest security standards while enabling the broader American technology ecosystem to support government missions." The Financial and Strategic Landscape Palantir's recent achievements have captured investor attention. With a 290% stock sur...

NovoCure Ltd ( NVCR ) announced groundbreaking results from its Phase 3 PANOVA-3 trial, sending its stock soaring by over 55%. The trial tested the company's Tumor Treating Fields (TTFields) therapy combined with standard chemotherapy in patients with locally advanced pancreatic cancer—a disease with notoriously poor survival rates. The study achieved its primary endpoint, showing a significant improvement in median overall survival (mOS). Patients receiving TTFields alongside gemcitabine and nab-paclitaxel achieved a median survival of 16.2 months, compared to 14.16 months for chemotherapy alone. Notably, the 24-month survival rate jumped by 33% for patients receiving TTFields. The non-invasive therapy, delivered through a wearable device, uses electric fields to disrupt cancer cell division while sparing healthy cells. This unique mechanism positions NovoCure as a potential disruptor in oncology, with regulatory filings planned for the U.S., EU, and Japan. Mixed Market Reactions ...

Intel Corporation ( INTC ) is undergoing a seismic shift in leadership following the abrupt retirement of CEO Pat Gelsinger. The announcement comes amid mounting investor frustration over the tech giant’s inability to regain its position as a leader in semiconductor manufacturing. Gelsinger, who took the helm in 2021 with ambitious plans to restore Intel’s dominance, has stepped down after a contentious board meeting. The board has appointed Chief Financial Officer David Zinsner and Executive Vice President Michelle Johnston Holthaus as interim co-CEOs, while Frank Yeary assumes the role of interim executive chair. The search for a permanent CEO is already underway. Investors initially welcomed the news, with Intel shares rising 5.3% on Monday. However, the enthusiasm masks deeper challenges for a company grappling with structural issues, fierce competition, and a demanding investor base. Intel’s Struggle to Catch Up Intel’s troubles are rooted in its loss of technological leadership i...